Zobrazeno 1 - 10
of 650
pro vyhledávání: ''
Autor:
Michael Bonelli, Stephan Blüml, Philipp Hofer, Leonhard X. Heinz, Stefan Winkler, Daniela Sieghart, Josef S Smolen, Marianne Graninger, Daniel Aletaha, Karin Stiasny, Helmuth Haslacher, Helga Radner, Selma Tobudic, Maximilian Koblischke, Renate Thalhammer, Thomas Perkmann, Daniel Mrak, Judith H. Aberle
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesEvidence suggests that B cell-depleting therapy with rituximab (RTX) affects humoral immune response after vaccination. It remains unclear whether RTX-treated patients can develop a humoral and T-cell-mediated immune response against SARS-C
Autor:
María Laura Acosta Felquer, Luciano LoGiudice, Enrique R. Soriano, María Laura Galimberti, Luis Daniel Mazzuoccolo, Javier Rosa
Publikováno v:
Annals of the Rheumatic Diseases. 81:74-79
ObjectivesTo compare the incidence of psoriatic arthritis (PsA) in patients with psoriasis (PsO) according to different treatments for their skin: topics/no treatment, conventional disease-modifying antirheumatic drugs (DMARDs) (cDMARDs) or biologica
Publikováno v:
Annals of the Rheumatic Diseases. 80:1393-1399
BackgroundHepatitis B surface antigen (HBsAg) reverse seroconversion (RS) can happen in patients with rheumatoid arthritis (RA) with resolved hepatitis B (RHB) undergoing biological disease-modifying antirheumatic drugs (bDMARDs). But the incidence a
Autor:
Antonio Manzo, Silvia Balduzzi, Eleonora Mauric, Laura Bogliolo, Fausto Baldanti, Terenzj Luvaro, Bernardo D’onofrio, Daniele Lilleri, Serena Bugatti, Maria Immacolata Greco, Ludovico De Stefano, Michele di Lernia, Irene Cassaniti, Iolanda Mazzucchelli, Carlomaurizio Montecucco
Publikováno v:
Annals of the Rheumatic Diseases. 80:1635-1638
Strategies aimed at expediting immunisation campaigns against COVID-19 include providing single vaccine doses to individuals with previous exposure to SARS-CoV-2 and delaying second doses. While such approaches are effective at the population level,
Autor:
Tena K. Li, Cheuk-Wan Yim, Junbin Huang, Lai-Shan Tam, Tommy Tsz-On Lam, Vincent Lo, James F. Griffith, Ho So, Isaac T Cheng, Jolie Lee, Kitty Y Kwok, Lin Shi, Vivian Wing-Yin Hung, Vivian W Y Lee, Sze-Lok Lau, Jack Lee, Ling Qin, Edmund K. Li, Evelyn Chow
Publikováno v:
Annals of the Rheumatic Diseases. 80:981-988
ObjectiveTo evaluate the effects of denosumab on erosion healing at 2–4 metacarpophalangeal (MCP) head as determined by high-resolution peripheral quantitative CT (HR-pQCT) in patients with rheumatoid arthritis (RA) with stable disease.MethodsThis
Autor:
Neelufar Mozaffarian, Daniel W. T Ching, Jonathan Kay, Z. Yin, Rene Westhovens, Chantal Tasset, John S. Sundy, Robert Landewé, Gerd R Burmester, Tatsuya Atsumi, William Stohl, Franziska Matzkies, Désirée van der Heijde, William F. C. Rigby, Osvaldo D. Messina, Arvind Chopra, Ying Guo, Beatrix Bartok, Angelika Jahreis
Publikováno v:
Annals of the Rheumatic Diseases
Objectives To investigate efficacy and safety of the Janus kinase-1 inhibitor filgotinib in patients with active rheumatoid arthritis (RA) with limited or no prior methotrexate (MTX) exposure. Methods This 52-week, phase 3, multicentre, double-blind
Autor:
Nirupam Purkayastha, Myles Lewis, Katriona Goldmann, W.S. Tan, Alessandra Nerviani, Stephen Kelly, Marie-Astrid Boutet, Tamás Lajtos, Costantino Pitzalis, Rebecca Hands
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo determine the relationship between synovial versus skin transcriptional/histological profiles in patients with active psoriatic arthritis (PsA) and explore mechanistic links between diseased tissue pathology and clinical outcomes.Methods
Autor:
Glen T D Thomson, In-Ho Song, Stephen Hall, Ricardo Blanco, Filip Van den Bosch, Louis Bessette, Cristiano A. F. Zerbini, Ryan DeMasi, Yihan Li, Roy Fleischmann, Jeffrey Enejosa, Y. Song
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesTo evaluate efficacy and safety of immediate switch from upadacitinib to adalimumab, or vice versa, in patients with rheumatoid arthritis with non-response or incomplete-response to the initial therapy.MethodsSELECT-COMPARE randomised patie
Autor:
Hendrik Schulze-Koops, Josef S Smolen, Jordi Gratacós, Roberto Caporali, Lingnan Li, Sreekumar G. Pillai, Peter Nash, Masato Okada, Philip J. Mease, Christophe Sapin, Hasan Tahir, Inmaculada de la Torre, M. Hojnik, Philippe Goupille, Soyi Liu Leage
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesSPIRIT head-to-head (H2H) is a 52-week (Wk) trial comparing ixekizumab (IXE) with adalimumab (ADA) for simultaneous American College of Rheumatology (ACR)50 and Psoriasis Area and Severity Index (PASI)100 responses in 566 patients (distribu
Autor:
Yoshihiko Sakurai, Satoshi Okada, Masato Yashiro, Nami Okamoto, Tomoko Matsuda, Hiroshi Fujii, Ryuta Nishikomori, Yuzaburo Inoue, Ikuo Okafuji, Naotomo Kambe, Yoko Ueki, Utako Kaneko, Masami Inoue, Mototsugu Doi, Naoki Kato, Nobuo Kanazawa, Hiroko Kobayashi, Junichi Hosokawa, Ichiro Kobayashi, Shuichi Ito, Syuji Takei, Kyoko Tonomura, Yasuhiro Kondo, Yoshikazu Otsubo, Atsushi Kawakami, Kazushi Izawa, Megumu K. Saito, Naomi Iwata, Teruhiko Makino, Osamu Ohara, Yuta Maruyama, Yoshitaka Honda, Shusaku Ito
Publikováno v:
Annals of the Rheumatic Diseases. 79:1492-1499
ObjectivesTo collect clinical information and NOD2 mutation data on patients with Blau syndrome and to evaluate their prognosis.MethodsFifty patients with NOD2 mutations were analysed. The activity of each NOD2 mutant was evaluated in HEK293 cells by